. . . . . "Paliperidone" . . . "Irritability" . . . . . . "Stigler et al. [10] evaluated the effectiveness and tolerability of paliperidone for irritability in ASD. In this 8-week, prospective, open-label study, 21 (84%) of 25 subjects with ASD (mean age, 15.3 years) were considered responders to paliperidone (mean dosage, 7.1 mg/day), based on Clinical Global Impression (CGI)- Improvement and Aberrant Behaviour Checklist-Irritability sub- scale.v" . . . . . . . "Children and adolescents (mean age 15.3 years)" . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB" . "NeH/8kC8VK3DP1/tbL1yIoGGwguuxVycaDYHS/YKAT8vvDD8/+NQBUt+nn0gOEvKZAtEJWG7dx5qf3KUY7GecQ/CYzgiGblTO7a2NDJELGVcI0k13Yb9uAPFcDNvQNIev0YqKJm5J3bUepHbAsFE8iCwoJOwEjVWB9cbIH+gYpk=" . . "2022-09-16T11:50:42.254483"^^ . . . "2.3.0" .